Fezolinetant - Menopausal disorders
You are here : Home > Formulary Search > Fezolinetant - Menopausal disorders
Status 1
No records returned.
Documentation
- No records returned.
PAD Profile
Other Indications
Below are listed other indications that Fezolinetant is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Menopausal disorders.
- Clonidine hydrochloride
- Conjugated oestrogens
- Conjugated oestrogens with medroxyprogesterone
- Drospirenone
- Duavive
- Estradiol
- Estradiol with dydrogesterone
- Estradiol with levonorgestrel
- Estradiol with medroxyprogesterone
- Estradiol with norethisterone
- Estradiol with progesterone
- Ethinylestradiol
- Gabapentin
- Levonorgestrel
- Medroxyprogesterone acetate
- Non-Hormonal lubricants
- Paroxetine
- Pregabalin
- Progesterone
- St Johns Wort
- Tibolone
- Venlafaxine
Committee Recommendations (1)
This drug has not yet been assessed for formulary status.
It has not yet been evaluated by NICE or the Surrey Heartlands ICS Area Prescribing Committee (APC). As such, advice regarding safety, effectiveness (including cost-effectiveness) and its place in therapy is yet to be determined.
Before prescribing this drug it is recommended that clinicians contact their Medicines Optimisation team to discuss possible alternatives/options.
NICE are due to publish guidance later this year and will be considered by the APC within 90 days. Date of NICE publication to be confirmed.